DEF 14A Filing

Company

Indaptus Therapeutics, Inc.

Filed

August 4, 2022

Period of Report

August 4, 2022

Accession Number

0001493152-22-021368

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →